Gelonghui, on December 31, announced that Zhejiang Garden Biopharmaceutical (300401.SZ) has revealed plans to establish a subsidiary in Macau to expand into domestic and international markets, enhancing the company's brand influence and market competitiveness. The subsidiary will primarily engage in research, production, and sales in the health sector.
The company is establishing a subsidiary in Macau to leverage its international platform to expand into domestic and international markets, enhancing brand influence and market competitiveness. At the same time, Macau has a solid industrial foundation and policy environment for health research, production, and sales, which is beneficial for the development of the company's health business.
